An observational study in Epilepsy, sponsored by Medial Research Ltd.. Terminated at 1 site in Israel. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-09-13.
Sponsored by Medial Research Ltd. · Observational
Epilepsy is a group of neurological disorders characterized by propensity for spontaneous epileptic seizures. Epileptic seizures are the result of excessive and abnormal nerve cell activity in the brain. About 0.7-1% of the world population suffers from seizures. The most common treatment is based on seizure medications that enables about 2/3 of the patients to control their seizures. However, about 20 million patients worldwide, suffer from unpredictable seizures without remedy, and are resistant to medication.
In this study EEG and other physiologic signals are collected using wearable sensors, from Epilepsy patients who are at risk of experiencing seizures. The collected signals will be used for developing algorithms that may identify pre-seizure and seizure related periods.
1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.
This study's enrollment of 28 is below the median of 102 across 521 observational studies indexed under Epilepsy.
Browse Epilepsy studies →This is the only study on the registry with Medial Research Ltd. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Adult epilepsy patients who are admitted to the video EEG unit and are expected to experience seizures during hospitalization
Exclusion Criteria:
Monitoring
Successful data collection during hospitalization
Continuous recording from wearable sensors of physiologic signals during hospitalization in the video EEG unit
Time frame: 12 hours daily for up to 5 days
Successful data collection during at home monitoring
Continuous recording from wearable sensors of physiologic signals during at home monitoring
Time frame: 12 hours daily for up to 14 days
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.